Rocket Lab's Defense Pivot Ignites Value Debate

Rocket Lab is currently in focus due to a multi-year contract with the U.S. government valued at $266 million for 12 suborbital launches, with options for six additional missions utilizing its Electron and HASTE rockets. This recent contract win, alongside substantial defense awards exceeding $1.3 billion, signals a significant "defense pivot" for the company.

Despite these positive developments, Rocket Lab's share price has faced pressure, with a 30-day return down 30.45% and a year-to-date return down 8.21%. However, this recent weakness contrasts with a very strong 1-year total shareholder return of 41.91%, indicating a cooling of momentum rather than a trend break.

Analysts suggest that Rocket Lab is currently undervalued, with a fair value estimate of approximately $85.04, significantly higher than its trading price of $69.75. This valuation perspective suggests the recent share price pullback might represent a discount opportunity. The bulk of the Tranche 3 award, exceeding $816 million, is not expected to impact revenue until 2027 and 2028, meaning investors focusing on trailing twelve-month revenue may be misinterpreting the company's financial trajectory.